Alterola Biotech Inc. (ABTI)

Overview

Alterola Biotech, Inc. is a pioneering pharmaceutical company that embarked on its journey in 2021, with its headquarters nestled in Birkenhead, the United Kingdom. The company has carved a niche in the development of cannabinoid and cannabinoid-like molecules, with a keen focus on innovating regulated human and animal health pharmaceuticals as well as regulated food products. Alterola Biotech, Inc. dedicates its resources to pushing the boundaries in the production of active pharmaceutical ingredients and food-grade ingredients. Furthermore, it prides itself on developing advanced formulation and drug delivery systems aimed at enhancing bioavailability, solubility, and stability of its products, thus ensuring they meet the highest standards of efficacy and safety.

Products and Services

• Regulated Human and Animal Health Pharmaceuticals

At the core of its product portfolio, Alterola Biotech, Inc. specializes in the development of pharmaceuticals that cater to both human and animal health markets. Leveraging the therapeutic potential of cannabinoid and cannabinoid-like molecules, the company aims to address a wide spectrum of medical conditions, thereby improving the quality of life for its beneficiaries.

• Regulated Food Products

Understanding the growing demand for healthier food options, Alterola Biotech, Inc. extends its expertise into the realm of regulated food products. These offerings are infused with food-grade ingredients derived from cannabinoids, designed to benefit consumers looking for nutritious and beneficial food supplements.

• Active Pharmaceutical Ingredients (API)

As a cornerstone of its manufacturing capability, Alterola invests in the production of high-quality active pharmaceutical ingredients. These APIs are integral to the pharmaceutical industry, serving as the building blocks for a multitude of medications and thus, play a critical role in the company's supply chain and product development strategies.

• Food-grade Ingredients

Complementing its pharmaceutical endeavors, Alterola focuses on the formulation of food-grade ingredients. These are meticulously developed to meet the stringent standards of food safety and quality, ensuring that partners and consumers receive ingredients that are both safe and of the highest quality for their food products.

• Formulation and Drug Delivery

Highlighting its innovative edge, Alterola Biotech, Inc. has developed proprietary technologies for formulation and drug delivery. These technologies are designed to overcome common challenges associated with cannabinoids, such as solubility and stability, enhancing the effectiveness of their applications in both pharmaceuticals and food products.